美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ayala Pharmaceuticals, Inc.

0.6036

0.0000

成交量：- -

成交額：- -

市值：2,570.75萬

市盈率：-0.08

高：0.6036

開：0.6036

低：0.6036

收：0.6036

52周最高：0.8010

52周最低：0.0011

股本：4,259.39萬

流通股本：1,810.09萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-7.9866

每股收益(LYR):-7.9866

淨資產收益率：-392.03%

總資產收益率：-181.05%

市淨率：-1.05

市盈率(LYR):-0.08

資料載入中...

總覽公司新聞資訊公告

美國OTC市場Advaxis, Inc.股價上漲190.39% 市值漲1200.98萬美元

美國OTC市場Advaxis, Inc.盤中異動早盤股價大漲46.06%

美國OTC市場Advaxis, Inc.股價上漲944.36% 市值跌3.53萬美元

美國OTC市場Advaxis, Inc.股價飆升24.39% 市值漲52.98萬美元

美國OTC市場Advaxis, Inc.股價拉升23.12% 市值漲40.37萬美元

美國OTC市場Advaxis, Inc.盤中異動下午盤急速跳水13.47%報0.035美元

美國OTC市場Advaxis, Inc.盤中異動早盤急速上漲15.56%

美國OTC市場Advaxis, Inc.股價重挫77.37% 市值跌109.71萬美元

美國OTC市場Advaxis, Inc.盤中異動股價大跌72.32%

美國OTC市場Advaxis, Inc.盤中異動臨近午盤快速拉升261.26%

美國OTC市場Advaxis, Inc.盤中異動早盤大幅拉升22.88%

美國OTC市場Advaxis, Inc.股價重挫18.62% 市值跌21.49萬美元

美國OTC市場Advaxis, Inc.股價重挫39.07% 市值跌121.98萬美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ADXS/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ADXS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADXS\",,,,,undefined,":{"symbol":"ADXS","market":"US","secType":"STK","nameCN":"Ayala Pharmaceuticals, Inc.","latestPrice":0.60355,"timestamp":1773777600000,"preClose":0.60355,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":18100900,"shares":42593900,"eps":-7.986625,"marketStatus":"盤前交易","change":0,"latestTime":"03-17 16:00:00 EDT 延時","open":0.60355,"high":0.60355,"low":0.60355,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-7.986625,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1773840600000},"marketStatusCode":1,"adr":0,"exchange":"EXPERT","adjPreClose":0.60355,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADXS\",,,,,undefined,":{"symbol":"ADXS","floatShares":18100900,"roa":"-181.05%","roe":"-392.03%","lyrEps":-7.986625,"shares":42593900,"dividePrice":0,"high":0.60355,"amplitude":0,"preClose":0.60355,"low":0.60355,"week52Low":0.0011,"pbRate":"-1.05","psRate":"1977.50","week52High":0.801,"institutionHeld":0,"latestPrice":0.60355,"eps":-7.986625,"divideRate":0,"volume":0,"delay":15,"ttmEps":-7.986625,"open":0.60355,"prevYearClose":0.0401,"prevWeekClose":0.57,"prevMonthClose":0.57,"prevQuarterClose":0.0401},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADXS\",params:#limit:5,,,undefined,":[{"date":"2026-03-09","symbol":"ADXS","amount":0.52,"announcedDate":"2026-02-03","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-03","defaultRemindTime":1773063000000,"name":"Ayala Pharmaceuticals, Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-06","payableDate":"2026-02-03","currency":"USD","dateTimestamp":1773028800000,"payDate":"2026-03-06"},{"market":"US","date":"2026-02-04","symbol":"ADXS","reason":null,"defaultRemindTime":1770215400000,"announcedDate":"2026-02-03","type":"delisting","dateTimestamp":1770181200000},{"market":"US","date":"2022-09-12","symbol":"ADXS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1662955200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2022-06-06","symbol":"ADXS","defaultRemindTime":1654522200000,"type":"split","dateTimestamp":1654488000000,"forFactor":80,"toFactor":1,"ratio":80},{"market":"US","date":"2021-09-10","symbol":"ADXS","fiscalQuarterEnding":"2021/07","expectedEps":-0.04,"name":null,"time":"盤前","type":"earning","dateTimestamp":1631246400000,"reportTimeType":"pre","actualEps":-0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADXS\",market:\"US\",,,undefined,":[{"executeDate":"2026-03-09","recordDate":"2026-02-03","paymentDate":"2026-03-06","value":0.52,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADXS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADXS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADXS","date":"2021-12-21","current":-2.2851,"percent":0.38764,"low":-10.115853,"twenty":-3.753596,"median":-1.301833,"eighty":-0.326835,"high":-0.062533,"avg":-2.182396,"sd":2.116831,"marketCap":43138111},"quantilePoints":[{"date":"2021-03-19","current":-4.431937,"twenty":-5.796985,"median":-1.301833,"eighty":-0.326835,"marketCap":100113027},{"date":"2021-03-26","current":-3.977108,"twenty":-5.710324,"median":-1.302029,"eighty":-0.327142,"marketCap":89838898},{"date":"2021-04-01","current":-3.893547,"twenty":-5.670327,"median":-1.302029,"eighty":-0.327142,"marketCap":87951325},{"date":"2021-04-09","current":-3.754464,"twenty":-5.550334,"median":-1.301833,"eighty":-0.326835,"marketCap":84809589},{"date":"2021-04-16","current":-2.766952,"twenty":-5.506336,"median":-1.301833,"eighty":-0.326835,"marketCap":62502681},{"date":"2021-04-23","current":-2.919356,"twenty":-5.457006,"median":-1.301833,"eighty":-0.326835,"marketCap":65945342},{"date":"2021-04-30","current":-3.009136,"twenty":-5.399676,"median":-1.302029,"eighty":-0.327142,"marketCap":67973368},{"date":"2021-05-07","current":-2.55291,"twenty":-5.377011,"median":-1.302029,"eighty":-0.327142,"marketCap":57667684},{"date":"2021-05-14","current":-2.271968,"twenty":-5.330347,"median":-1.302029,"eighty":-0.327142,"marketCap":51321479},{"date":"2021-05-21","current":-3.346877,"twenty":-5.301015,"median":-1.302224,"eighty":-0.327449,"marketCap":75602609},{"date":"2021-05-28","current":-3.001807,"twenty":-5.239686,"median":-1.302224,"eighty":-0.327449,"marketCap":67807815},{"date":"2021-06-04","current":-3.175869,"twenty":-5.194355,"median":-1.302224,"eighty":-0.327449,"marketCap":71739702},{"date":"2021-06-11","current":-3.202742,"twenty":-5.101067,"median":-1.302224,"eighty":-0.327449,"marketCap":72346731},{"date":"2021-06-18","current":-3.338925,"twenty":-4.858321,"median":-1.302224,"eighty":-0.327449,"marketCap":71362844},{"date":"2021-06-25","current":-3.372996,"twenty":-4.685103,"median":-1.302224,"eighty":-0.327449,"marketCap":72091037},{"date":"2021-07-02","current":-3.255111,"twenty":-4.566651,"median":-1.302224,"eighty":-0.327449,"marketCap":69571491},{"date":"2021-07-09","current":-3.366863,"twenty":-4.498845,"median":-1.302224,"eighty":-0.327449,"marketCap":71959962},{"date":"2021-07-16","current":-3.060908,"twenty":-4.466254,"median":-1.302224,"eighty":-0.327449,"marketCap":65420795},{"date":"2021-07-23","current":-2.957334,"twenty":-4.429881,"median":-1.302224,"eighty":-0.327449,"marketCap":63207091},{"date":"2021-07-30","current":-2.807423,"twenty":-4.397371,"median":-1.302224,"eighty":-0.327449,"marketCap":60003045},{"date":"2021-08-06","current":-2.971643,"twenty":-4.319203,"median":-1.302224,"eighty":-0.327449,"marketCap":63512931},{"date":"2021-08-13","current":-2.927351,"twenty":-4.272365,"median":-1.302224,"eighty":-0.327449,"marketCap":62566281},{"date":"2021-08-20","current":-2.634344,"twenty":-4.24616,"median":-1.302224,"eighty":-0.327449,"marketCap":56303828},{"date":"2021-08-27","current":-3.194465,"twenty":-4.207084,"median":-1.301833,"eighty":-0.326835,"marketCap":68275309},{"date":"2021-09-03","current":-3.159032,"twenty":-4.144564,"median":-1.301833,"eighty":-0.326835,"marketCap":67517989},{"date":"2021-09-10","current":-3.190377,"twenty":-4.12073,"median":-1.301833,"eighty":-0.326835,"marketCap":68187926},{"date":"2021-09-17","current":-4.037112,"twenty":-4.102884,"median":-1.301833,"eighty":-0.326835,"marketCap":76212605},{"date":"2021-09-24","current":-4.087258,"twenty":-4.062507,"median":-1.301833,"eighty":-0.326835,"marketCap":77159255},{"date":"2021-10-01","current":-4.023226,"twenty":-4.026063,"median":-1.301833,"eighty":-0.326835,"marketCap":75950456},{"date":"2021-10-08","current":-3.625918,"twenty":-3.978738,"median":-1.301833,"eighty":-0.326835,"marketCap":68450075},{"date":"2021-10-15","current":-3.749353,"twenty":-3.966062,"median":-1.301833,"eighty":-0.326835,"marketCap":70780291},{"date":"2021-10-22","current":-3.885132,"twenty":-3.950462,"median":-1.301833,"eighty":-0.326835,"marketCap":73343527},{"date":"2021-10-29","current":-3.735467,"twenty":-3.933481,"median":-1.301833,"eighty":-0.326835,"marketCap":70518141},{"date":"2021-11-05","current":-3.854273,"twenty":-3.918915,"median":-1.301833,"eighty":-0.326835,"marketCap":72760974},{"date":"2021-11-12","current":-3.425335,"twenty":-3.905807,"median":-1.301833,"eighty":-0.326835,"marketCap":64663475},{"date":"2021-11-19","current":-2.909992,"twenty":-3.888494,"median":-1.301833,"eighty":-0.326835,"marketCap":54934826},{"date":"2021-11-26","current":-2.967852,"twenty":-3.868828,"median":-1.301833,"eighty":-0.326835,"marketCap":56027115},{"date":"2021-12-03","current":-2.655406,"twenty":-3.846404,"median":-1.301833,"eighty":-0.326835,"marketCap":50128757},{"date":"2021-12-10","current":-2.683179,"twenty":-3.806425,"median":-1.301833,"eighty":-0.326835,"marketCap":50653056},{"date":"2021-12-17","current":-2.391563,"twenty":-3.767552,"median":-1.301833,"eighty":-0.326835,"marketCap":45147922},{"date":"2021-12-21","current":-2.2851,"twenty":-3.753596,"median":-1.301833,"eighty":-0.326835,"marketCap":43138111}],"updateTime":1773839192520},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADXS\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2592336431","title":"美國OTC市場Advaxis, Inc.股價上漲190.39% 市值漲1200.98萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592336431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592336431?lang=zh_tw&edition=fundamental","pubTime":"2025-12-19 01:25","pubTimestamp":1766078700,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日01时25分，美国OTC市场Advaxis, Inc.股票出现异动，股价急速上涨190.39%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.59%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219012500a45c6c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219012500a45c6c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","ADXS","BK4139"],"gpt_icon":0},{"id":"2568239182","title":"美國OTC市場Advaxis, Inc.盤中異動 早盤股價大漲46.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568239182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568239182?lang=zh_tw&edition=fundamental","pubTime":"2025-09-18 22:29","pubTimestamp":1758205741,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日22时29分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅拉升46.06%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918222901a4cdeb10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918222901a4cdeb10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","BK4139","ADXS"],"gpt_icon":0},{"id":"2566162586","title":"美國OTC市場Advaxis, Inc.股價上漲944.36% 市值跌3.53萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566162586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566162586?lang=zh_tw&edition=fundamental","pubTime":"2025-09-10 00:29","pubTimestamp":1757435397,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日00时29分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速拉升944.36%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910002957a71a0c5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910002957a71a0c5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXSD","BK4139","ADXS"],"gpt_icon":0},{"id":"2558666646","title":"美國OTC市場Advaxis, Inc.股價飆升24.39% 市值漲52.98萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558666646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558666646?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 22:04","pubTimestamp":1754921047,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时04分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅拉升24.39%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811220407a48223f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811220407a48223f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXS","ADXSD"],"gpt_icon":0},{"id":"2558579570","title":"美國OTC市場Advaxis, Inc.股價拉升23.12% 市值漲40.37萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558579570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558579570?lang=zh_tw&edition=fundamental","pubTime":"2025-08-09 01:25","pubTimestamp":1754673901,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时25分，美国OTC市场Advaxis, Inc.股票出现异动，股价大幅拉升23.12%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809012501a47daae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809012501a47daae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXS","ADXSD"],"gpt_icon":0},{"id":"2557233938","title":"美國OTC市場Advaxis, Inc.盤中異動 下午盤急速跳水13.47%報0.035美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557233938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557233938?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 03:42","pubTimestamp":1754336520,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时42分，美国OTC市场Advaxis, Inc.股票出现波动，股价快速下跌13.47%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为1.60%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805034200a474f523&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805034200a474f523&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","BK4139","ADXSD"],"gpt_icon":0},{"id":"2554438777","title":"美國OTC市場Advaxis, Inc.盤中異動 早盤急速上漲15.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554438777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554438777?lang=zh_tw&edition=fundamental","pubTime":"2025-07-28 22:14","pubTimestamp":1753712041,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时14分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅上涨15.56%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728221401a467e875&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728221401a467e875&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","ADXSD","BK4139"],"gpt_icon":0},{"id":"2551218401","title":"美國OTC市場Advaxis, Inc.股價重挫77.37% 市值跌109.71萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551218401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551218401?lang=zh_tw&edition=fundamental","pubTime":"2025-07-14 21:48","pubTimestamp":1752500882,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时48分，美国OTC市场Advaxis, Inc.股票出现波动，股价急速下挫77.37%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214802a6a8f774&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214802a6a8f774&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","BK4139","ADXSD"],"gpt_icon":0},{"id":"2550963716","title":"美國OTC市場Advaxis, Inc.盤中異動 股價大跌72.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550963716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550963716?lang=zh_tw&edition=fundamental","pubTime":"2025-07-12 01:51","pubTimestamp":1752256261,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日01时51分，美国OTC市场Advaxis, Inc.股票出现波动，股价快速下跌72.32%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712015101a6a44ac0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712015101a6a44ac0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXSD","ADXS"],"gpt_icon":0},{"id":"2548346819","title":"美國OTC市場Advaxis, Inc.盤中異動 臨近午盤快速拉升261.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548346819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548346819?lang=zh_tw&edition=fundamental","pubTime":"2025-07-02 23:54","pubTimestamp":1751471641,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日23时54分，美国OTC市场Advaxis, Inc.股票出现波动，股价大幅上涨261.26%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702235401a72aefb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702235401a72aefb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXSD","ADXS"],"gpt_icon":0},{"id":"2547015317","title":"美國OTC市場Advaxis, Inc.盤中異動 早盤大幅拉升22.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547015317?lang=zh_tw&edition=fundamental","pubTime":"2025-06-30 23:12","pubTimestamp":1751296321,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日23时12分，美国OTC市场Advaxis, Inc.股票出现异动，股价快速上涨22.88%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630231202a4c6ee40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630231202a4c6ee40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXSD","ADXS"],"gpt_icon":0},{"id":"2546747831","title":"美國OTC市場Advaxis, Inc.股價重挫18.62% 市值跌21.49萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546747831","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546747831?lang=zh_tw&edition=fundamental","pubTime":"2025-06-27 22:50","pubTimestamp":1751035802,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日22时50分，美国OTC市场Advaxis, Inc.股票出现异动，股价快速跳水18.62%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627225002a721230a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627225002a721230a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADXSD","ADXS"],"gpt_icon":0},{"id":"2546263392","title":"美國OTC市場Advaxis, Inc.股價重挫39.07% 市值跌121.98萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546263392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546263392?lang=zh_tw&edition=fundamental","pubTime":"2025-06-26 04:13","pubTimestamp":1750882381,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日04时13分，美国OTC市场Advaxis, Inc.股票出现波动，股价快速下跌39.07%。美国OTC市场Advaxis, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。美国OTC市场Advaxis, Inc.公司简介：Ayala Pharmaceuticals Inc是一家处于临床阶段的肿瘤学公司，专注于开发和商业化针对罕见和侵袭性癌症患者的小分子疗法，主要是在基因界定的患者人群中。该公司目前的候选产品组合AL101和AL102目标是利用γ-分泌酶抑制剂异常激活Notch途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626041301a71d9366&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626041301a71d9366&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADXS","ADXSD","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}